Valerie H. Odegard, Ph.D. - Publications

Affiliations: 
2005 Yale University, New Haven, CT 
Area:
immunology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Cox JH, Hussell S, Søndergaard H, Roepstorff K, Bui JV, Deer JR, Zhang J, Li ZG, Lamberth K, Kvist PH, Padkjær S, Haase C, Zahn S, Odegard VH. Antibody-mediated targeting of the Orai1 calcium channel inhibits T cell function. Plos One. 8: e82944. PMID 24376610 DOI: 10.1371/journal.pone.0082944  0.92
2006 Odegard VH, Schatz DG. Targeting of somatic hypermutation. Nature Reviews. Immunology. 6: 573-83. PMID 16868548 DOI: 10.1038/nri1896  0.92
2006 Inlay MA, Gao HH, Odegard VH, Lin T, Schatz DG, Xu Y. Roles of the Ig kappa light chain intronic and 3' enhancers in Igk somatic hypermutation. Journal of Immunology (Baltimore, Md. : 1950). 177: 1146-51. PMID 16818772 DOI: 10.4049/jimmunol.177.2.1146  0.92
2005 Rush JS, Liu M, Odegard VH, Unniraman S, Schatz DG. Expression of activation-induced cytidine deaminase is regulated by cell division, providing a mechanistic basis for division-linked class switch recombination. Proceedings of the National Academy of Sciences of the United States of America. 102: 13242-7. PMID 16141332 DOI: 10.1073/pnas.0502779102  0.92
2005 Odegard VH, Kim ST, Anderson SM, Shlomchik MJ, Schatz DG. Histone modifications associated with somatic hypermutation. Immunity. 23: 101-10. PMID 16039583 DOI: 10.1016/j.immuni.2005.05.007  0.92
Show low-probability matches.